Other

Payments to Acquire Investments

Thermo Fisher Scientific Payments to Acquire Investments decreased by 94.7% to $14.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 94.7%, from $264.00M to $14.00M.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026May 1, 2026

How to read this metric

Increases suggest a strategy of diversifying capital or building strategic partnerships, while decreases may indicate a focus on core operations.

Detailed definition

This represents cash outflows for the purchase of financial assets, such as equity stakes in other companies, debt secur...

Peer comparison

Commonly found in the investing section of the cash flow statement as 'Payments to acquire investments' or 'Purchases of securities'.

Metric ID: other_payments_to_acquire_investments

Historical Data

8 periods
 Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q1 '26
Value$2.00M$186.00M$12.00M$1.76B$20.00M$287.00M$264.00M$14.00M
QoQ Change>999%-93.5%>999%-98.9%>999%-8.0%-94.7%
YoY Change>999%-89.2%>999%-85.0%-94.7%
Range$2.00M$1.76B
CAGR+204.0%
Avg YoY Growth>999%
Median YoY Growth-85.0%
Current Streak2 quarters decline

Payments to Acquire Investments at Other Companies

Frequently Asked Questions

What is Thermo Fisher Scientific's payments to acquire investments?
Thermo Fisher Scientific (TMO) reported payments to acquire investments of $14.00M in Q1 2026.
How has Thermo Fisher Scientific's payments to acquire investments changed year-over-year?
Thermo Fisher Scientific's payments to acquire investments decreased by 94.7% year-over-year, from $264.00M to $14.00M.
What does payments to acquire investments mean?
Cash used to purchase financial investments or equity stakes in other entities.